Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2025-12-24 @ 5:00 PM
NCT ID:
NCT06343350
Eligibility Criteria:
Inclusion Criteria:
1. Having met the criteria established by either the World Health Organization (WHO) or the American Diabetes Association (ADA):
2. Age 22 or older
3. Understand the study and volunteer to sign the informed consent
Exclusion Criteria:
1. Unable to understand the study
2. Unwilling to sign informed consent
3. Indicate persistent vision loss, blurred vision, or floaters
4. Previous diagnosis of macular edema, diabetic retinopathy (any level) proliferative retinopathy, radiation retinopathy, or retinal vein occlusion
5. History of laser treatment of the retina or injections into either eye, or any history of retinal surgery
6. Currently participating in another investigational eye study or actively receiving investigational product for diabetic retinopathy or diabetic macular edema
7. A condition that, in the opinion of the investigator, would preclude participation in the study
8. Contraindicated for imaging by fundus imaging systems used in the study because of hypersensitivity to light, recently underwent photodynamic therapy, or was taking medication that causes photosensitivity
9. Known pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
22 Years
Study:
NCT06343350
Study Brief:
Protocol Section:
NCT06343350